H2020 project on In-silico Development- and Clinical-Trial-Platform for Testing in-situ Tissue Engineered Heart Valves

Joined February 2021
20 Photos and videos
28 Dec 2024
πŸš€ #SimInSitu Update! We’re closing the year with 10 peer-reviewed publications on THV testing and patient-specific modeling! In 2025, expect more on: βœ… Tissue regeneration βœ… FSI modeling βœ… VVUQ (ASME V&V 40) Excited for what’s next! πŸ”¬ #Innovation #VVUQ #FSI #H2020
1
21
28 Dec 2024
Exciting progress in the H2020 #SimInSitu project! We validated a patient-specific TAVI model for testing tissue-engineered heart valves (THVs), achieving <10% error in structural predictions. This sets the stage for evaluating Xeltis' biodegradable TAVI device! πŸš€ #TAVI
15
26 Oct 2024
Milestone #8 achieved! The Sapien-3 ETR heart valve model is now verified and validated within the SimInSitu project. Using in-silico methods and validated components, we’re pushing innovation in valve design. Sensitivity & uncertainty analyses add robustness. #SimInSitu
15
10 May 2024
Excited to announce Milestone #15: successful patient-specific modeling of tissue-engineered heart valves in young patients! #medicalinnovation #milestone
2
32
25 Mar 2024
πŸŽ‰ Milestone Alert! SimInSitu project achieves breakthrough in TAVI evaluation with patient-specific simulations. Using SAPIEN 3 device, we've virtually treated aortic valve stenosis. Tailored simulations align closely with clinical outcomes. #TAVI #MedicalSimulation
1
44
5 Mar 2024
Join us at #VPH2024 in Stuttgart, Germany! πŸ‡©πŸ‡ͺ SIMCor, SimInSitu, and SimCardioTest are teaming up to host a session on cardiovascular modeling. Abstract submission deadline extended to 22 MARCH. Don't miss out – submit your paper now! vph.tik.uni-stuttgart.de
3
44
21 Feb 2024
Exciting news: Leartiker researchers uncover insights into scaffold material fatigue, aiding biomedical advancements. #MaterialScience #BiomedicalEngineering πŸ§ͺπŸ”¬
2
32
20 Jan 2024
"πŸŽ‰ SimInSitu Project Milestone! πŸ₯ Validated S3 TAVI Device FSI Model using SPH method in Abaqus. Achieved <10% error, robust for patient-specific simulations. 🌐 #SimInSitu #MedicalSimulation"
1
5
84
26 Dec 2023
Happy Christmas and New Year
1
56
siminsitu retweeted
3 Dec 2023
πŸ“… Join us on Feb 6-7, 2024, in #Leuven, #Belgium for #InnovaHeart2024! This European workshop focuses on #digitalheart innovations in cardiovascular medicine, uniting academics, start-ups, and industry leaders in in-silico modeling. #cardiovascular #simulation #research
8
10
682
13 Dec 2023
Collaborated at #KU_Leuven and #EMSE to model #Xeltis carotid conduit's tissue growth and remodeling. Translated animal trial data to a computational model, capturing tissue adaptation and scaffold degradation. Exciting steps at #H2020 project
1
1
3
183
17 Oct 2023
At TU-Graz, our research group just released two groundbreaking papers on electrospun polymers for Xeltis' heart valves. These studies tackle complex biomechanical issues and provide valuable insights. Dive in looking at our Newsletter: siminsitu.eu/blog
1
28
21 May 2023
Developing a non-invasive approach to estimate patient-specific material properties for individuals undergoing #TAVI. This innovative approach relies on #FEA modeling and dynamic CT imaging data to minimize discrepancies between FEAs and actual CT shapes #H2020,
4
130
16 Feb 2023
Look at our an in-silico model of Pulmonary Heart Valve. More informatio at our website siminsitu.eu/
1
6
681
siminsitu retweeted
30 Jan 2023
4RealSim, as the SimInSitu - In-silico Development- and Clinical-Trial-Platform Consortium leader, is excited to share with you the invitation to the INNOVAHEART workshop. This event is organized by our fellow SimCardioTest EU project eHealth_EU consort…lnkd.in/ecrbRa4r
1
2
153
21 Dec 2022
Merry Christmas from the SimInSitu consortium
1
2
222
siminsitu retweeted
Save the date: 22 March 2023 in Bordeaux, France. For the first time, five EU funded projects join their forces to bring together different actors of the #insilico #cardiovascular ecosystem, during a one-day workshop. more information on: bit.ly/innovaheart
4
14
1,009
10 Oct 2022
The MS2 milestone successfully concludes the scaffold characterisation and Uncertainty Quantification (Epistemic and Aleatoric uncertainty) of three scaffold materials used in Xeltis for in-situ tissue-engineered heart valves in WP1
4
siminsitu retweeted
#VPH2022 is great science, hands-on workshops, student activities, community and networking... all of this in the amazing setting of one of the most charming cities of Portugal: Porto πŸŒ‰πŸ·πŸ’― We are waiting for you there!
5
12